| 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors C Sheng, J Zhu, W Zhang, M Zhang, H Ji, Y Song, H Xu, J Yao, Z Miao, ... European journal of medicinal chemistry 42 (4), 477-486, 2007 | 44 | 2007 |
| 3D-QSAR study of a series of novel benzofuran NMT inhibitors J Zhu, CQ Sheng, M Zhang, YL Song, J Chen, JX Yu, JZ Yao, ZY Miao, ... CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE 27 (2), 287-291, 2006 | 3 | 2006 |
| 3D-QSAR study of a series of novel triazole antifungal compounds CQ Sheng, WN ZHANG, M ZHANG, YL SONG, J CHEN, J ZHU, HT JI, ... Acta Chimica Sinica 63 (7), 617, 2005 | 5 | 2005 |
| 白色念珠菌 N-肉豆蔻酰基转移酶中药物结合位点的 MCSS 分析 盛春泉， 朱杰， 张万年， 徐辉， 宋云龙， 张珉， 姚建忠， 缪震元 高等学校化学学报 29 (1), 117-123, 2008 | | 2008 |
| 中国化学快报 2011, 22 (03) 272-275 DOI: ISSN: 1001-8417 CN: 11-2710/O6 JH Jiang, XF Liu, CH Zhen, YJ Zhou, J Zhu, JG Lv, CQ Sheng | | |
| A Case Report of Talaromyces marneffei Infection Repeatedly Misdiagnosed as Tuberculosis in an HIV-Negative Patient K Pan, G Zhao, W Fang, C Sheng, Q Zhao, Y He, AJ Chen, W Liao, ... Dermatological Health 1 (3), 9-16, 2023 | | 2023 |
| A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment J Fu, P Zhang, Z Sun, G Lu, Q Cao, Y Chen, W Wu, J Zhang, C Zhuang, ... Acta Pharmaceutica Sinica B 14 (5), 2228-2246, 2024 | 1 | 2024 |
| A Fluorescent Probe for Imaging p53–MDM 2 Protein–Protein Interaction Z Liu, Z Miao, J Li, K Fang, C Zhuang, L Du, C Sheng, M Li Chemical Biology & Drug Design 85 (4), 411-417, 2015 | 14 | 2015 |
| A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S)-21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I … Z Miao, L Zhu, G Dong, C Zhuang, Y Wu, S Wang, Z Guo, Y Liu, S Wu, ... Journal of Medicinal Chemistry 56 (20), 7902-7910, 2013 | 50 | 2013 |
| A novel drug discovery strategy: Mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways C Zhuang, C Sheng, WS Shin, Y Wu, J Li, J Yao, G Dong, W Zhang, ... Oncotarget 5 (21), 10830, 2014 | 12 | 2014 |
| A novel route for the synthesis of androgen receptor antagonist enzalutamide X Meng, S Bi, S Jin, K Wu, S Wu, L Shao, PA Bonnet, C Sheng Chinese Chemical Letters 34 (6), 108096, 2023 | | 2023 |
| A novel strategy for development of glucocorticoids through non-genomic mechanism J Zhou, M Li, CQ Sheng, L Liu, Z Li, Y Wang, JR Zhou, ZP Jing, YZ Chen, ... Cellular and molecular life sciences 68, 1405-1414, 2011 | 24 | 2011 |
| A theranostic probe of indoleamine 2, 3-dioxygenase 1 (IDO1) for small molecule cancer immunotherapy Y Wu, Y Zhang, X Chen, Y Hu, G Dong, Y Guo, C Sheng European Journal of Medicinal Chemistry 213, 113163, 2021 | 5 | 2021 |
| Absorption of 5’-OL-valinyl ester of ara-C in rat intestine using in situ single pass perfusion model 临床药学 | | |
| Acrosin structure-based design, synthesis and biological activities of 7-azaindol derivatives as new acrosin inhibitors JH Jiang, XF Liu, CH Zhen, YJ Zhou, J Zhu, JG Lv, CQ Sheng Chinese Chemical Letters 22 (3), 272-275, 2011 | 10 | 2011 |
| Advance in anti-cancer lead-compounds derived from natural products WU Shanchao, S Chunquan, Z Wannian 药学实践与服务 32 (5), 337-341,371, 2014 | 2 | 2014 |
| Advances in signal regulation and detection strategies for autophagy in fungal cells. WZ Yang, J Tu, N Liu, CQ Sheng | 1 | 2020 |
| Advances of validation of bioactive small molecule targets S CHEN, G DONG, C SHENG, W ZHANG Journal of Pharmaceutical Practice, 97-102, 2016 | | 2016 |
| Advances on small-molecule inhibitors of interfacing with p53-MDM2 protein-protein interactions C ZHUANG, Z MIAO, C SHENG, J YAO, W ZHANG Chinese Journal of Medicinal Chemistry, 2010 | | 2010 |
| Allosteric modulators of protein–protein interactions (PPIs) D Ni, N Liu, C Sheng Protein Allostery in Drug Discovery, 313-334, 2019 | 27 | 2019 |
